Literature DB >> 8380975

Improvements in survival by aggressive resections of hilar cholangiocarcinoma.

H U Baer1, S C Stain, A R Dennison, B Eggers, L H Blumgart.   

Abstract

The operative management of hilar cholangiocarcinoma has evolved because of advances in diagnostic imaging that have permitted improved patient selection, and refinements in operative techniques that have lowered operative mortality rates. Over a 4-year period, 48 patients with hilar cholangiocarcinoma were managed. Twenty-seven patients were treated by palliative measures. Preoperative investigation identified 29 patients who were judged fit for operation without proven irresectability by radiologic studies, and 21 of the 29 patients had tumor removal (72%). Twenty-three operative procedures were performed: local excision (n = 12) (two had subsequent hepatic resection), and hepatic resection primarily (n = 9). Eight patients had complications (35%), and one patient died (4.3%). The mean actuarial survival after local excision in 36 months, and after hepatic resection, 32 months. Palliation as assessed by personal interview was excellent for more than 75% of the months of survival. A combination of careful patient selection and complete radiologic assessment will allow an increased proportion of patients to be resected by complex operative procedures with low mortality rate, acceptable morbidity rate, and an increase in survival with an improved quality of life.

Entities:  

Mesh:

Year:  1993        PMID: 8380975      PMCID: PMC1242729          DOI: 10.1097/00000658-199301000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  43 in total

1.  Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice.

Authors:  R L Thompson; M Hoper; T Diamond; B J Rowlands
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

Review 2.  Research into the results of resection of hilar bile duct cancer.

Authors:  E J Boerma
Journal:  Surgery       Date:  1990-09       Impact factor: 3.982

3.  The role of U tube palliative treatment in high bile duct carcinoma.

Authors:  J Terblanche; D Kahn; P C Bornman; D Werner
Journal:  Surgery       Date:  1988-06       Impact factor: 3.982

4.  Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer.

Authors:  C W Pinson; R L Rossi
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

5.  Resection or palliation: priority of surgery in the treatment of hilar cancer.

Authors:  H Bismuth; D Castaing; O Traynor
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

6.  Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer.

Authors:  R Pichlmayr; B Ringe; W Lauchart; W O Bechstein; G Gubernatis; E Wagner
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

7.  Expandable metallic biliary endoprostheses: preliminary clinical evaluation.

Authors:  T Yoshioka; H Sakaguchi; H Yoshimura; T Tamada; H Ohishi; H Uchida; S Wallace
Journal:  Radiology       Date:  1990-10       Impact factor: 11.105

8.  Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival.

Authors:  T Tsuzuki; M Ueda; S Kuramochi; S Iida; S Takahashi; H Iri
Journal:  Surgery       Date:  1990-09       Impact factor: 3.982

9.  Carcinoma of the hepatic hilus. Surgical management and the case for resection.

Authors:  B Launois; J P Campion; P Brissot; M Gosselin
Journal:  Ann Surg       Date:  1979-08       Impact factor: 12.969

10.  Percutaneous cholangioscopic or transpapillary insertion of self-expanding biliary metal stents.

Authors:  H Neuhaus; F Hagenmüller; M Griebel; M Classen
Journal:  Gastrointest Endosc       Date:  1991 Jan-Feb       Impact factor: 9.427

View more
  28 in total

1.  Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.

Authors:  J I Tsao; Y Nimura; J Kamiya; N Hayakawa; S Kondo; M Nagino; M Miyachi; M Kanai; K Uesaka; K Oda; R L Rossi; J W Braasch; J M Dugan
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Liver transplantation is not indicated for cholangiocarcinoma.

Authors:  C Wright Pinson; Derek E Moore
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

3.  Operative considerations in resection of hilar cholangiocarcinoma.

Authors:  Alexander A Parikh; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

4.  Surgical palliation for unresectable hilar cholangiocarcinoma.

Authors:  S Connor; S J Wigmore; K K Madhavan; R W Parks; O J Garden
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

5.  Principles of surgical resection in hilar cholangiocarcinoma.

Authors:  Emilio Ramos
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

6.  Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma.

Authors:  Ryusei Matsuyama; Daisuke Morioka; Ryutaro Mori; Yasuhiro Yabushita; Seigo Hiratani; Yohei Ota; Takafumi Kumamoto; Itaru Endo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

7.  Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution.

Authors:  Alfred Wei-Chieh Kow; Choi Dong Wook; Sun Choon Song; Woo Seok Kim; Min Jung Kim; Hyo Jun Park; Jin Soek Heo; Seong Ho Choi
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

8.  Perioperative hepatic functional risk assessed with technetium-99m diethylenetriamine pentaacetic acid-galactosyl human serum albumin liver scintigraphy in patients undergoing pancreaticoduodenectomy complicated by obstructive jaundice.

Authors:  H Nakano; K Kumada; Y Takekuma; S Hasebe; Y Yoshizawa; M Yamaguchi; D Jaeck
Journal:  Int J Pancreatol       Date:  1999-02

9.  Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization.

Authors:  Seiji Kawasaki; Hiroshi Imamura; Akira Kobayashi; Terumasa Noike; Shiro Miwa; Shin-ichi Miyagawa
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

10.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.